246 related articles for article (PubMed ID: 33537555)
1. Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease.
Monteonofrio L; Florio MC; AlGhatrif M; Lakatta EG; Capogrossi MC
Vasc Biol; 2021; 3(1):R1-R14. PubMed ID: 33537555
[TBL] [Abstract][Full Text] [Related]
2. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
[TBL] [Abstract][Full Text] [Related]
3. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
Cano F; Gajardo M; Freundlich M
Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
[TBL] [Abstract][Full Text] [Related]
4. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.
Coto E; Avanzas P; Gómez J
Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961
[TBL] [Abstract][Full Text] [Related]
5. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
6. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations.
Maranduca MA; Vamesu CG; Tanase DM; Clim A; Drochioi IC; Pinzariu AC; Filip N; Dima N; Tudorancea I; Serban DN; Serban IL
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556919
[TBL] [Abstract][Full Text] [Related]
7. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
8. ACE2, the Counter-Regulatory Renin-Angiotensin System Axis and COVID-19 Severity.
Triposkiadis F; Xanthopoulos A; Giamouzis G; Boudoulas KD; Starling RC; Skoularigis J; Boudoulas H; Iliodromitis E
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501332
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System.
Lumpuy-Castillo J; Lorenzo-Almorós A; Pello-Lázaro AM; Sánchez-Ferrer C; Egido J; Tuñón J; Peiró C; Lorenzo Ó
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899833
[TBL] [Abstract][Full Text] [Related]
10. Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury.
Ventura D; Carr AL; Davis RD; Silvestry S; Bogar L; Raval N; Gries C; Hayes JE; Oliveira E; Sniffen J; Allison SL; Herrera V; Jennings DL; Page RL; McDyer JF; Ensor CR
Open Forum Infect Dis; 2021 Oct; 8(10):ofab170. PubMed ID: 34642634
[TBL] [Abstract][Full Text] [Related]
11. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System.
Michaud V; Deodhar M; Arwood M; Al Rihani SB; Dow P; Turgeon J
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32635289
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
13. Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.
Liu MY; Zheng B; Zhang Y; Li JP
Chronic Dis Transl Med; 2020 Jun; 6(2):98-105. PubMed ID: 32550040
[TBL] [Abstract][Full Text] [Related]
14. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
Brojakowska A; Narula J; Shimony R; Bander J
J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
[TBL] [Abstract][Full Text] [Related]
15. Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2.
Kaur U; Acharya K; Mondal R; Singh A; Saso L; Chakrabarti S; Chakrabarti SS
Eur J Pharmacol; 2020 Nov; 887():173545. PubMed ID: 32926917
[TBL] [Abstract][Full Text] [Related]
16. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
Son M; Seo J; Yang S
Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences.
Maranduca MA; Tanase DM; Cozma CT; Dima N; Clim A; Pinzariu AC; Serban DN; Serban IL
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145655
[TBL] [Abstract][Full Text] [Related]
18. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
Vázquez-Cornejo E
Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
Zemlin AE; Wiese OJ
Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
[TBL] [Abstract][Full Text] [Related]
20. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Valencia I; Peiró C; Lorenzo Ó; Sánchez-Ferrer CF; Eckel J; Romacho T
Front Pharmacol; 2020; 11():1161. PubMed ID: 32848769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
